Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.18) by 77.78 percent. This is a 100 percent decrease over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $135.00 thousand which missed the analyst consensus estimate of $300.00 thousand by 55.00 percent. This is a 54.70 percent decrease over sales of $298.00 thousand the same period last year.
How To Watch US World Cup Games, Betting Odds And How The England Vs. US Game Could Set Records
The 2022 World Cup kicked off with its first of 64 matches on Sunday, Nov. 20. For the first time since 2014, fans of the U.S. Men’s National Team (Team USA) will be able to watch their team in World Cup competition.
Here are the details on how to watch, betting odds and the highly anticipated Team USA vs. England matchup.
